ArticleVaccines2025

Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in Indonesia: A Single-Blinded Randomized Controlled Trial.

Nina Dwi Putri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.